Elspeth Bedford
Papers
2
Total Citations
346
H-Index
2
About
Dr. Elspeth Bedford is a leading urologic oncologist whose research is reshaping the surgical management of bladder cancer. Her work centers on evaluating the comparative effectiveness and economic value of robot-assisted radical cystectomy (RARC) against traditional open surgery. Dr. Bedford’s landmark 2022 study, cited over 320 times, provided critical evidence on whether total intracorporeal robotic surgery improves 90-day recovery and morbidity compared to open radical cystectomy, directly informing clinical decision-making for patients with muscle-invasive disease. She further advanced the field by conducting a rigorous cost-effectiveness analysis in 2023, demonstrating the economic implications of adopting robotic techniques for payers and healthcare systems. By integrating clinical outcomes with health economics, Dr. Bedford’s research helps surgeons and hospitals weigh the benefits of advanced technology against its costs. Her work is essential reading for anyone interested in evidence-based surgical innovation, value-based care, and the future of minimally invasive oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2